EUVIMEDEUVIMED entdecken
Crossref

Incidences and Clinical Outcomes of Patients with a Single or Dual Chamber Implantable Cardioverter-Defibrillator Developing an Indication for Cardiac Resynchronization Therapy

Ines Quataert, Maarten Blondeel, Sander Trenson, Sebastian Ingelaere, Peter Haemers, Tomas Robyns, Joris Ector, Jens-Uwe Voigt, Rik Willems, Christophe Garweg, Bert Vandenberk iD, Gabor Voros

European Journal of Heart Failure · 2025

DOI: 10.1002/ejhf.3728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Ines Quataert und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, UZ Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Cardiac Resynchronization Therapy, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Frans Van de Werf Fund for Clinical Cardiovascular Research (Leuven, Belgium), J.U.V. holds a personal research mandate, R.W. is supported as postdoctoral clinical researcher.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

While studies have shown worse clinical outcomes in patients with an implantable cardioverter-defibrillator (ICD) who underwent an upgrade to cardiac resynchronization therapy (CRT) when compared to de novo CRT implantations, little is known about the clinical trajectory of these patients prior to upgrading to CRT. Methods and results This single-centre retrospective study included patients with ischaemic or non-ischaemic cardiomyopathy with a QRS duration <130 ms who underwent ICD implantation between 2010 and 2022. By reviewing the evolution of QRS duration, QRS morphology, and right ventricular pacing (RVP) percentages, it was assessed whether the patients developed an indication for CRT according to contemporary European Society of Cardiology guidelines during the follow-up. A total of 517 patients were included: median age at implant 63.8 years (range 55.5–70.2 years), 17.8% female, 29.4% secondary prevention, 65.2% ischaemic cardiomyopathy, and 53.8% single-chamber or subcutaneous ICD implants. Over a median follow-up of 6.6 years, 132 (25.5%) patients developed an indication for CRT corresponding to an incidence of 4.52% per year, of which only 46 (34.8%) actually underwent an upgrade to CRT. Independent predictors of developing an indication for CRT were baseline QRS duration (hazard ratio [HR] 1.06/ms; 95% confidence interval [CI] 1.04–1.07) and age at implant (HR 1.04/year; 95% CI 1.02–1.06). An upgrade to CRT was associated with lower all-cause mortality, heart transplant, or assist device implant (log-rank p = 0.002) compared to patients who developed a CRT indication without upgrade to CRT.

Conclusions

One-quarter of patients implanted with an ICD who had a narrow QRS duration at the time of implantation developed an indication for CRT during a median follow-up of 6.6 years. Yet, the majority of these patients did not undergo an upgrade to CRT, underscoring potential gaps in CRT utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableCardiac Resynchronization TherapyHeart FailureHumansFemaleMaleMiddle AgedRetrospective StudiesAgedIncidenceTreatment OutcomeFollow-Up Studies

Stichwörter der Autor:innen

Cardiac resynchronization therapyHeart failureImplantable cardioverter‐defibrillatorUpgrade

Autor:innen und Institutionen

  • Department of Cardiology, UZ Leuven, Leuven, Belgium.
  • Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Department of Cardiology, Sint-Jan Hospital Bruges, Bruges, Belgium.

ORCID-Profile: Bert Vandenberk

Förderung

  • Frans Van de Werf Fund for Clinical Cardiovascular Research (Leuven, Belgium)
  • J.U.V. holds a personal research mandate
  • R.W. is supported as postdoctoral clinical researcher

Zitieren

APA

Quataert, I., Blondeel, M., Trenson, S., Ingelaere, S., Haemers, P., Robyns, T., Ector, J., Voigt, J. U., Willems, R., Garweg, C., Vandenberk, B., & Voros, G. (2025). Incidences and Clinical Outcomes of Patients with a Single or Dual Chamber Implantable Cardioverter-Defibrillator Developing an Indication for Cardiac Resynchronization Therapy. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3728

Vancouver

Quataert I, Blondeel M, Trenson S, Ingelaere S, Haemers P, Robyns T, et al. Incidences and Clinical Outcomes of Patients with a Single or Dual Chamber Implantable Cardioverter-Defibrillator Developing an Indication for Cardiac Resynchronization Therapy. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.3728

BibTeX
@article{Quataert2025,
  author = {Quataert, Ines and Blondeel, Maarten and Trenson, Sander and Ingelaere, Sebastian and Haemers, Peter and Robyns, Tomas and Ector, Joris and Voigt, Jens-Uwe and Willems, Rik and Garweg, Christophe and Vandenberk, Bert and Voros, Gabor},
  title = {Incidences and Clinical Outcomes of Patients with a Single or Dual Chamber Implantable Cardioverter-Defibrillator Developing an Indication for Cardiac Resynchronization Therapy},
  journal = {European Journal of Heart Failure},
  year = {2025},
  doi = {10.1002/ejhf.3728}
}
Kostenlos starten →